Samil Pharmaceutical, Cube Entertainment and other 5companies disclose financing totaling hundreds of billions of won
Samil Pharmaceutical and CSA Cosmic disclosed convertible bonds, while Axion Group, Cube Entertainment and Sambo Industrial disclosed 3rights offerings to existing shareholders, respectively. The total amount raised was in the tens of billions to 100hundreds of millions of won.
Samil Pharmaceutical announced the issuance of its 24th 100convertible bonds worth hundreds of millions of won in a disclosure dated 2026year 6month 11day. The conversion price is 7,245won, and the conversion exercise period was specified. The purpose of the issuance and the conversion terms were included in the disclosure.
Axion Group said it had decided on a 59hundred million 9,999ten thousand 9,830won rights offering to existing shareholders, according to a disclosure dated 3year 2026month 6day. The company stated that it would issue 11ten thousand 500new common shares. The method of allocating the new shares is a 3rights offering to existing shareholders.
CSA Cosmic announced the issuance of its 5th 50convertible bonds worth hundreds of millions of won in a disclosure dated 2026year 6month 11day. The conversion price is 251won. The disclosure announced the commencement date for exercising conversion rights on the convertible bonds.
Cube Entertainment decided to conduct a 100 billion won third-party allotment paid-in capital increase to raise funds for operating expenses and other purposes, and disclosed the decision on 3. 2026 year, 6 month, 12 day. The company specified operating expenses and other purposes as the purpose of the fundraising. The specific issuance terms can be confirmed in the disclosure.
Sambo Industrial decided to conduct a 27 billion 8,600 million won third-party allotment paid-in capital increase worth approximately, for the purpose of acquiring securities of another corporation and other purposes, and disclosed the decision on 3. 2026 year, 6 month, 12 day. The company stated the fundraising purpose and the number of shares to be issued in the disclosure. The issuance method is a 3-party allotment.
Each of the above disclosures includes detailed terms such as the issuance size and method, the purpose of the fundraising, and the conversion price. Investors can directly check the issuance terms and schedule, as well as information on new-share subscribers, in the original disclosure.